Mirati Therapeutics, Inc. Pre-Tax Profit Margin 2013-2023 | MRTX
Mirati Therapeutics, Inc. pre-tax profit margin from 2013 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Pre-Tax Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
2023-09-30 |
$0.04B |
$-0.73B |
-1910.53% |
2023-06-30 |
$0.03B |
$-0.74B |
-2729.63% |
2023-03-31 |
$0.02B |
$-0.74B |
-4088.89% |
2022-12-31 |
$0.01B |
$-0.74B |
-6158.33% |
2022-09-30 |
$0.01B |
$-0.74B |
-6700.00% |
2022-06-30 |
$0.08B |
$-0.64B |
-821.79% |
2021-09-30 |
$0.07B |
$-0.48B |
-648.65% |
2020-12-31 |
$0.01B |
$-0.36B |
-2753.85% |
2020-09-30 |
$0.01B |
$-0.33B |
-2741.67% |
2020-03-31 |
$0.00B |
$-0.26B |
-8633.33% |
2019-12-31 |
$0.00B |
$-0.21B |
-5325.00% |
2019-09-30 |
$0.01B |
$-0.17B |
-2816.67% |
2018-12-31 |
$0.01B |
$-0.10B |
-825.00% |